Fig. 2From: Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluationClinical potential of biomarkers (CTCs, ctDNA, ncRNA, EVs, tumor metabolites, TEP) in different biofluids (blood, urine, pleural fluid, saliva) for early diagnosis, prognostic evaluation, monitoring treatment response, recurrence and metastasis monitoring of lung cancerBack to article page